Results 141 to 150 of about 4,245 (206)

Long-term efficacy and safety of peptide receptor radionuclide therapy in Japanese patients with unresectable neuroendocrine tumor: extension of the Japanese phase I and phase I/II study. [PDF]

Ann Nucl Med
Kobayashi N, Ono H, Okubo N, Akahoshi K, Kudo A, Ban D, Ichikawa Y.   +6 more
europepmc   +1 more source

Prognostic implications of [¹⁸F]FDG PET and metabolic changes in patients with advanced metastatic neuroendocrine tumors undergoing rechallenge PRRT: final results from a multicenter 10-year survival WARMTH study. [PDF]

Theranostics
Santo G, Rodrigues M, Paez D, Morozova O, Kabasakal L, Kairemo K, Grana CM, Baum RP, di Santo G, Virgolini IJ.   +9 more
europepmc   +1 more source

Radionuclide theranostics: advances and clinical applications in lung cancer. [PDF]

Front Oncol
Yang Y, Fu J, Tang S, Liu T, Hu H, Guo H, Wen L, Yang Y, Liu C, Zhang Y, Yu L, Zhou H.   +11 more
europepmc   +1 more source

Intra-arterial peptide receptor radionuclide therapy (IA-PRRT) in patients with SSTR-expressing neuroendocrine neoplasms: short- and long-term safety and efficacy for up to 13 years. [PDF]

Theranostics
Zhang J, Mensel B, Baum RP.
europepmc   +1 more source

Multimodal strategies for diagnosing and treating thyroid cancer: Advances in basic and clinical research. [PDF]

Transl Oncol
Zhao Y, Su Y, Wu Y, Mourdi N, Ji Y, Wang Z.   +5 more
europepmc   +1 more source

Relationship between absorbed dose and SUV derived from SPECT/CT imaging and dose-response in patients with neuroendocrine tumors treated with [¹⁷⁷Lu]Lu-DOTA-TATE. [PDF]

EJNMMI Res
Liu F, Yang H, Zhang J, Li J, Qiao Y, Chen J, Song S.   +6 more
europepmc   +1 more source

Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma. [PDF]

AACE Endocrinol Diabetes
Yu R, Gardner L, Salavati A, Bahri S.
europepmc   +1 more source

Management of Peptide Receptor Radionuclide Therapy Toxicities in Neuroendocrine Neoplasm Patients. [PDF]

Curr Treat Options Oncol
Mohindroo C, Ramirez RA.
europepmc   +1 more source

Medical Management of Well-Differentiated Pancreatic Neuroendocrine Tumors: From Conventional Therapies to Emerging Strategies. [PDF]

J Clin Med
Sung MJ, Park N.
europepmc   +1 more source